跳至主要内容
临床试验/NCT04035499
NCT04035499已完成不适用

A Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms

University of Rochester2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2020年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
2
主要终点
Feasibility: Retention Rates

研究概览

简要总结

This is a pilot study to evaluate the feasibility of a mobile health exercise intervention (GO-EXCAP Mobile App) over 7 weeks in 25 patients with myeloid neoplasms receiving hypomethylating agents.

详细描述

Up to 98% of older patients with myeloid neoplasms experience physical function decline, fatigue, and mood disturbances. Mobile health exercise interventions are promising strategy to prevent physical function decline and improve fatigue and mood disturbances, but older patients with myeloid neoplasms receiving hypomethylating agents are understudied. The proposed study will evaluate a novel mobile health exercise intervention that is adapted to older patients with myeloid neoplasms receiving outpatient hypomethylating agents and investigate whether and how exercise can prevent physical function decline, improve fatigue and mood disturbances, and prevent worsening quality of life.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age is greater than or equal to 60 years
  • Have a diagnosis of MN
  • Receiving outpatient chemotherapy (e.g., HMA)
  • English speaking
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
  • No medical contraindications for exercise per oncologist
  • Able to walk 4 meters as part of Short Physical Performance Battery measured walk (with or without assistive device)
  • Able to provide informed consent

排除标准

  • Platelet count of 10,000 per microliter or less in the most recent blood draw (due to risk of spontaneous bleeding) prior to transfusion (i.e., patients are allowed to enroll if their platelet count is 10,000 per microliter or less but is scheduled to receive transfusion the day of consent)

结局指标

主要结局

Feasibility: Retention Rates

时间窗: 8-12 weeks

Retention rates (percentage of patients who are enrolled i.e., complete baseline assessments and subsequently complete post-intervention assessments)

Feasibility: Percentage of Patients Entering Any Exercise Data Into the Mobile App ≥50% of the Study Period Days, Excluding Hospitalization

时间窗: 8-12 weeks

Percentage of patients entering any exercise data into the mobile app ≥50% of the study period days, excluding hospitalization

Feasibility: Percentage of Patients Entering Resistance Data Into the Mobile App ≥50% of the Study Period Days, Excluding Hospitalization

时间窗: 8-12 weeks

Percentage of Patients Entering Resistance Data Into the Mobile App ≥50% of the Study Period Days, Excluding Hospitalization

Feasibility: Recruitment Rates

时间窗: Week 0, prior to baseline

Recruitment rates (percentage of patients who are approached and subsequently consent).

次要结局

  • Pre-post Changes in Brief Fatigue Inventory (BFI)(Baseline, Post-Intervention, Changes from baseline to post-intervention (an average of 8-12 weeks))
  • Pre-post Changes in Short Physical Performance Battery (SPPB)(Baseline, Post-Intervention, Changes from baseline to post-intervention (an average of 8-12 weeks))
  • Pre-post Changes in the Center for Epidemiological Studies Depression Scale (CES-D)(8-12 weeks)
  • Pre-post Changes in Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu)(Baseline, Post-Intervention, Changes from baseline to post-intervention (an average of 8-12 weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kah Poh Loh

Associate Professor - Department of Medicine, Hematology/Oncology (SMD)

University of Rochester

研究点 (2)

Loading locations...

相似试验